A prospective crossover randomized controlled trial evaluating the efficacy of texture and color enhancement imaging (TXI) for identification of colorectal neoplasms
Not Applicable
- Conditions
- colorectal neoplasms
- Registration Number
- JPRN-UMIN000048038
- Lead Sponsor
- Yokohama Sakae Kyosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients in disagreement with informed consent. 2. Patients with inadequate bowel preparation (BBPS: score0 or 1). 3. Patients with previous right-sided colorectal resection. 4. Patients with inflammatory bowel disease. 5. Patients with familial adenomatous polyposis. 6. Patients with Peytz-Jeghers syndrome. 7. Patients with hereditary polyposis syndromes. 8. Other, patients deemed by the treating physician to be ineligible for inclusion in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method